Sector: Health Care
Director information for COOPER INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Albert G. White III | CEO; President & Chief Executive Officer | 56 | ["B.S. in Finance","MBA","Experience as Chief Financial Officer","Experience as EVP and Chief Strategy Officer","Leadership roles across CooperCompanies","Director at KeyBanc Capital Markets"] | ["Compensation Committee","Audit Committee"] | 2026 |
| Barbara A. Carbone | Director | 67 | ["Audit leader with nearly 40 years of experience","Advising global companies across medical device, manufacturing, and technology sectors","Strong financial oversight","Former Audit Partner at KPMG LLP","Chairperson of KPMG Partnership Audit Committee"] | ["Audit","Compensation"] | 2026 |
| Colleen E. Jay | Chairman of the Board | 63 | ["35 years of experience running multinational, multibillion-dollar businesses","Expertise in innovation, brand building, organizational leadership, strategic alternatives, and transformational growth","Served as a Global Division President for Procter and Gamble until retirement in October 2017","Experience leading large global businesses","Extensive board and committee leadership"] | ["Organization & Compensation (Chair)","Risk"] | 2026 |
| Cynthia L. Lucchese | Chair; Independent Director | 65 | ["over 30 years of senior corporate leadership","nearly 20 years as a CFO","expertise in strategy, M&A, international business, finance, and accounting","extensive board and governance experience across numerous healthcare and medical device companies"] | ["Corporate Governance & Nominating","Organization & Compensation"] | 2026 |
| Gerard H. Warner III | President, CooperVision, Inc. | 61 | ["B.S. in Business Administration in Marketing from Villanova University","M.B.A. from The Simon School of Business, University of Rochester","17 years at Bausch + Lomb in various marketing and management roles","Various Vice President and Senior Vice President positions with CooperVision"] | [] | 2026 |
| Holly R. Sheffield | President, CooperSurgical, Inc. | 55 | ["Over 20 years of experience in investment banking","Managing Director, Global Head of Medical Technology at UBS Securities LLC","Experience at Credit Suisse","Experience at Donaldson, Lufkin & Jenrette","B.S. from Cornell University","M.B.A. from Columbia Business School"] | [] | 2026 |
| Lawrence E. Kurzius | Director; Chairman of the Board | 68 | ["global business leader","CEO experience","long-range strategic planning","consumer marketing","human capital management","enterprise risk management","driving performance and sustained growth"] | ["Corporate Governance & Nominating","Organization & Compensation"] | 2026 |
| Maria Rivas, M.D. | Director | 62 | ["Physician executive","More than 25 years of experience in medical devices and pharmaceuticals","Former Global Chief Medical Officer at Pfizer, Inc.","Led medical affairs and pharmacovigilance at Merck KGaA","Served as SVP of Global Medical Affairs at Merck & Co","Extensive experience in medical affairs at AbbVie and Bayer Healthcare","Endocrinologist in private practice"] | ["Audit","Corporate Governance & Nominating"] | 2026 |
| Robert S. Weiss | Independent Director | 79 | ["Over five decades of strategic, financial, and operational experience in medical devices and healthcare","Expertise in global contact lens and women’s health markets","Former President and CEO of CooperCompanies","Former Chief Operating Officer and EVP of CooperCompanies","Former Chief Financial Officer and Treasurer of CooperCompanies","Led CooperVision into daily disposable and silicone hydrogel lens business","Served as director of Accuray Incorporated and on its nominating, governance, and audit committees","Board of Trustees member at the University of Scranton with service on finance, advancement, and audit committees","B.S. in Accounting from the University of Scranton"] | [] | 2026 |
| Teresa S. Madden | Chair; Director | 70 | ["Accomplished financial executive","Active CPA","More than three decades of public company experience","Led all finance functions as CFO of a Fortune 300 company","Financial oversight through service on public company audit committees","Experience managing annual capital investment spend in excess of $3 billion","Experience with external financing requirements ranging from $1-$2 billion","Held progressively senior financial positions at various companies"] | ["Audit"] | 2026 |
| Walter M Rosebrough, Jr. | Director; Independent Chair of the Board | 71 | ["40+ years in healthcare industry","25 years as CEO in medical devices","experience in product development, M&A, marketing, manufacturing, and finance","MBA from Stanford University","BIE from Kettering University","served on several healthcare industry boards"] | ["Corporate Governance & Nominating"] | 2026 |
